Document Detail

Observational study on efficacy of negative expiratory pressure test proposed as screening for obstructive sleep apnea syndrome among commercial interstate bus drivers--protocol study.
Jump to Full Text
MedLine Citation:
PMID:  22151802     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Obstructive sleep apnea (OSA) is a respiratory disease characterized by the collapse of the extrathoracic airway and has important social implications related to accidents and cardiovascular risk. The main objective of the present study was to investigate whether the drop in expiratory flow and the volume expired in 0.2 s during the application of negative expiratory pressure (NEP) are associated with the presence and severity of OSA in a population of professional interstate bus drivers who travel medium and long distances.
METHODS/DESIGN: An observational, analytic study will be carried out involving adult male subjects of an interstate bus company. Those who agree to participate will undergo a detailed patient history, physical examination involving determination of blood pressure, anthropometric data, circumference measurements (hips, waist and neck), tonsils and Mallampati index. Moreover, specific questionnaires addressing sleep apnea and excessive daytime sleepiness will be administered. Data acquisition will be completely anonymous. Following the medical examination, the participants will perform a spirometry, NEP test and standard overnight polysomnography. The NEP test is performed through the administration of negative pressure at the mouth during expiration. This is a practical test performed while awake and requires little cooperation from the subject. In the absence of expiratory flow limitation, the increase in the pressure gradient between the alveoli and open upper airway caused by NEP results in an increase in expiratory flow.
DISCUSSION: Despite the abundance of scientific evidence, OSA is still underdiagnosed in the general population. In addition, diagnostic procedures are expensive, and predictive criteria are still unsatisfactory. Because increased upper airway collapsibility is one of the main determinants of OSA, the response to the application of NEP could be a predictor of this disorder. With the enrollment of this study protocol, the expectation is to encounter predictive NEP values for different degrees of OSA in order to contribute toward an early diagnosis of this condition and reduce its impact and complications among commercial interstate bus drivers.
TRIAL REGISTRATION: Registro Brasileiro de Ensaios Clinicos (local acronym RBEC) [Internet]: Rio de Janeiro (RJ): Instituto de Informaçao Cientifica e Tecnologica em Saude (Brazil); 2010 - Identifier RBR-7dq5xx. Cross-sectional study on efficacy of negative expiratory pressure test proposed as screening for obstructive sleep apnea syndrome among commercial interstate bus drivers; 2011 May 31 [7 pages]. Available from http://www.ensaiosclinicos.gov.br/rg/RBR-7dq5xx/.
Authors:
Raquel P Hirata; Isabella C Aguiar; Sergio R Nacif; Lilian C Giannasi; Fernando S S Leitão Filho; Israel R Santos; Salvatore Romano; Newton S Faria; Paula N Nonaka; Luciana M M Sampaio; Claudia S Oliveira; Paulo T C Carvalho; Geraldo Lorenzi-Filho; Alberto Braghiroli; Adriana Salvaggio; Giuseppe Insalaco; Luis V F Oliveira
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-12-07
Journal Detail:
Title:  BMC pulmonary medicine     Volume:  11     ISSN:  1471-2466     ISO Abbreviation:  BMC Pulm Med     Publication Date:  2011  
Date Detail:
Created Date:  2012-02-16     Completed Date:  2012-05-10     Revised Date:  2013-06-27    
Medline Journal Info:
Nlm Unique ID:  100968563     Medline TA:  BMC Pulm Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  57     Citation Subset:  IM    
Affiliation:
Master's and Doctoral Degree Programs in Rehabilitation Sciences, Nove de Julho, University, Sao Paulo, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cardiovascular Diseases / epidemiology*
Cross-Sectional Studies
Humans
Male
Mass Screening
Metabolic Syndrome X / epidemiology*
Motor Vehicles*
Observation
Polysomnography
Questionnaires
Reproducibility of Results
Research Design
Sleep Apnea, Obstructive / diagnosis*,  epidemiology
Spirometry
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): BMC Pulm Med
ISSN: 1471-2466
Publisher: BioMed Central
Article Information
Download PDF
Copyright ©2011 Hirata et al; licensee BioMed Central Ltd.
open-access:
Received Day: 21 Month: 9 Year: 2011
Accepted Day: 7 Month: 12 Year: 2011
collection publication date: Year: 2011
Electronic publication date: Day: 7 Month: 12 Year: 2011
Volume: 11First Page: 57 Last Page: 57
ID: 3280188
Publisher Id: 1471-2466-11-57
PubMed Id: 22151802
DOI: 10.1186/1471-2466-11-57

Observational study on efficacy of negative expiratory pressure test proposed as screening for obstructive sleep apnea syndrome among commercial interstate bus drivers - protocol study
Raquel P Hirata1 Email: raquel_hirata@hotmail.com
Isabella C Aguiar1 Email: bellaaguiar@yahoo.com.br
Sergio R Nacif2 Email: pro_ar@uol.com.br
Lilian C Giannasi3 Email: odontogiannasi@uol.com.br
Fernando SS Leitão Filho4 Email: fernandostudart@uol.com.br
Israel R Santos1 Email: ireissantos@uol.com.br
Salvatore Romano5 Email: romano@ibim.cnr.it
Newton S Faria, Jr1 Email: nsdfj@yahoo.com.br
Paula N Nonaka1 Email: paulanaomi@gmail.com
Luciana MM Sampaio1 Email: lucianamalosa@uninove.br
Claudia S Oliveira1 Email: csantos@uninove.br
Paulo TC Carvalho1 Email: ptpaulo@terra.com.br
Geraldo Lorenzi-Filho6 Email: geraldo.lorenzi@incor.usp.br
Alberto Braghiroli7 Email: alberto.braghiroli@fsm.it
Adriana Salvaggio5 Email: salvaggio@ibim.cnr.it
Giuseppe Insalaco5 Email: giuseppe.insalaco@ibim.cnr.it
Luis VF Oliveira1 Email: oliveira.lvf@pq.cnpq.br
1Master's and Doctoral Degree Programs in Rehabilitation Sciences, Nove de Julho, University, Sao Paulo, Brazil
2Pulmonary Division, Servidor Publico do Estado de Sao Paulo Hospital, Sao Paulo, Brazil
3School of Dentistry, Julio Mesquita Filho State University, Sao Jose dos Campos, Brazil
4Department of Medicine, Fortaleza University, Fortaleza, Brazil
5National Research Council of Italy, Institute of Biomedicine and Molecular Immunology "A. Monroy", Palermo, Italy
6Sleep Laboratory, Pulmonary Division, Heart Institute (InCor) Sao Paulo University, Medicine School, Sao Paulo, Brazil
7Sleep Laboratory, Medical Center of Veruno, Salvatore Maugeri Foundation, Veruno (NO) Italy

Background

Sleep disorders are common throughout the world and have living effects on modern industrialized "24-hour" societies. The consequences of such disorders include excessive sleepiness, a negative effect on social and recreational activities, a decreased physical ability, a decline in productivity and a high risk of accidents [1]. These conditions, which are associated to acute or chronic insomnia, chronic sleep restriction, work shifts, jet lag, narcolepsy and obstructive sleep apnea (OSA), are a public health concern.

There is a large body of evidence demonstrating that sleepiness contributes toward industrial and traffic accidents [2]. It has previous been reported that 22% of accidents are caused by excessive sleepiness and 17-19% of traffic deaths are the result of sleepiness at the wheel [3]. The medical and economic costs of traffic accidents are estimated to be 1 to 3% of the gross domestic product of a country (annual cost of approximately 518 billion dollars). The Instituto de Pesquisa Econômica Aplicada (IPEA) [Institute of Applied Economic Research] of the Brazilian Federal Government reports that the mean cost of traffic accidents in Brazil is US$ 5,167,000, among which US$ 1,919.000 are spent on victimless accidents, US$ 2,942,000 are spent on accidents that result in injuries and US$ 2,476,000 are spent on accidents involving deaths [4].

OSA is a respiratory disease characterized by the collapse of the upper airways which occurs during sleep in predisposed subjects. Following chronic obstructive pulmonary disease and asthma, OSA is the epidemiological most important and widespread respiratory disease, affecting 3 to 7% of the male population and 2 to 5% of the female population between 40 and 65 years of age in the western world [5]. In Brazil, prevalence even larger was encountered according to an epidemiological study carried out in the city of Sao Paulo, where 24.8% males and 9.6% females were OSA patients [6].

One of the most important social implications of OSA is the increased risk for driving accidents [7]. Pack et al. (2002) reported a prevalence of 28% in a population of professional truck drivers [8]. The main cause of road accidents among professional drivers is lack of sleep, disturbance in the sleep/wake cycle (shift workers) and sleep disorders [9,10].

There is a close relationship between OSA and the risk of cardiovascular disease [11-13], neuropsychological problems [14,15], reduction in quality of life [16,17] and increase in the use of health resources [18,19], demonstrating that, when under-diagnosed, OSA can have serious consequences. Thus, the identification of new markers for OSA can be of considerable relevance for clinical practice.

An increase in the upper airway collapsibility is one of the main determinants of OSA [20,21]. Investigators have identified anatomical factors [22-24], neuromuscular control factors [25,26] and liquid and fat deposits [27] that may lead to increased pharyngeal collapsibility during sleep.

The negative expiratory pressure (NEP) method was initially used to assess intrathoracic expiratory flow limitations in patients with chronic obstructive pulmonary disease [28]. However, NEP test in individuals with OSA was found to lead to a collapse of the extrathoracic airway, with a drop in expiratory flow below the preceding expiration, which is common among patients with OSA [29-32]. The NEP test is carried out by administering negative pressure at the mouth during expiration. This maneuver is easy to perform and requires minimal patient cooperation. NEP test is based on the pressure gradient increase between the alveoli and open upper airway that results in an increase in expiratory flow. This study will allow the use of new screening technique to detect upper airway collapsibility, a high risk indicator for OSA in professional drivers. It's a daytime, low-cost screening method that could be included in a preventive strategy aimed at reducing the impact of this condition on accidents and the development of cardiovascular consequences.

Objectives

The main objective of the study, which will be conducted on medium and long distance professional interstate bus drivers, is to investigate whether NEP test induced upper airway collapse is indicative for the presence and severity of OSA. Secondary objectives are: 1) identify the prevalence of OSA in this population; 2) determine the prevalence of metabolic syndrome and cardiovascular disease; 3) determine the correlation of work shift on clinical findings; and 4) validate a novel questionnaire on sleep quality proposed by the Italian National Research Council Institute of Biomedicine and Molecular Immunology "A. Monroy" and Centro Medico di Veruno (Italy).


Methods/Design
Study design

An observational, analytical study will be carried out at the Sleep Laboratory of the Master's and Doctoral Postgraduate Program in Rehabilitation Sciences of the Nove de Julho University (Brazil) (Figure 1). The design, conduction and reporting of this study will follow the norms of the "Standards for the Reporting of Diagnostic accuracy studies" - STARD statement.

Subjects

Male professional bus drivers of an interstate roadway firm will be invited to participate in the study. The community-based sample includes shift workers: individuals working regular night shifts (from 10:00 pm to 08:00 am), individuals working regular day shifts (from 08:00 am to 06:00 pm), and subjects working rotating shifts.

With regard to the inclusion criteria, the sample will be made up by medium and long distance drivers, agreeing to participate in the study through a signed informed consent form. Subjects with acute pulmonary or heart disease and/or major cranio-facial or upper airway abnormalities, drug users and alcoholics will be excluded from the study.

Protocol

The initial population of professional bus drivers includes 710 subjects. All will be asked to be part of the study and all procedures will be clarified. Those who agree to participate will undergo a detailed patient history, physical examination involving determination of blood pressure, anthropometric data, circumference measurements (hips, waist and neck), tonsils and Mallampati index. Moreover, specific questionnaires addressing sleep apnea and excessive daytime sleepiness will be administered. Data acquisition will be completely anonymous. Following the medical examination, the participants will perform a spirometry, NEP test and standard overnight polysomnography.

Physical examination

Weight and height evaluation will be performed through an electronic balance (model 200/5, Welmy Industria e Comercio Ltda, Sao Paulo, Brazil) and body mass index (BMI) will be calculated [33]. For the assessments of tonsils and Mallampati index, subjects will be in the sitting position and instructed to open the mouth as much as possible [34,35].

Waist circumference will be measured with the subject in the upright position, standing at the midpoint between the costal margin and the iliac crest at the end of normal expiration. The hip circumference will be measured with the subject in the same position at the level of the greater trochanter. Neck circumference will be measured with the subject in the sitting position at the edge of the cricoid cartilage.

OSA and excessive daytime sleepiness questionnaires

The Berlin Questionnaire will be administered. This 10-item questionnaire has recognized efficacy in distinguishing subjects at greater risk for OSA in primary care population [36]. The Epworth Sleepiness Scale [37] will be used for the assessment of excessive daytime sleepiness. Moreover, a novel OSA questionnaire designed by researchers of the Italian National Research Council - Institute of Biomedicine and Molecular Immunology "A. Monroy" and Centro Medico di Veruno will be administered.

Spirometry

The spirometry will be carried out during the day, with the patient seated in a comfortable position. For such, the KoKo PFT System Version 4.11 (nSpire Health, Inc; Louisville, CO, USA) will be used following national guidelines for the execution of lung function tests by the Brazilian Society of Pneumology [38] and the European Respiratory Society [39]. The subjects will perform the test in a comfortable position, with the body erect and the upper limbs unsupported. All examinations will be carried out by a competent technician trained in obtaining the necessary cooperation from the subjects and appropriately operating the equipment in order to ensure accurate, reproducible results. The equipment will be calibrated prior to each exam with a 3-L syringe [38].

Negative expiratory pressure - NEP test

The NEP test is performed through the administration of negative pressure at the mouth during expiration. This is a practical test performed while awake and requires little cooperation from the subject. In the absence of expiratory flow limitation, the increase in the pressure gradient between the alveoli and open upper airway caused by NEP results in an increase in expiratory flow.

NEP will be generated by a Super Air Amplifier (Exair model 120021 Cincinnati, Ohio, USA) coupled to a tank of compressed air via an electrically operated solenoid valve (Norgren Ltd model 95004; Vimercate, MI, Italy) automatically activated in early expiration and kept open for 2 s by software control (Figure 2). A pneumotachograph (Hans Rudolph model 3830; Kansas City, MO, USA) will be connected to the air amplifier and the mouthpiece to measure airflow () with pressure transducers (PCLA02X5; Sensortechnics GmbH, Puchheim, Germany). Mouth pressure will be measured by pressure transducers (PCLA0050; Sensortechnics GmbH, Puchheim, Germany). NEP of 10 cm H2O will be set by occluding the pneumotachograph with a stopper and adjusting the flow of compressed air to air amplifier (Figure 2).

NEP maneuvers will be performed (each after at least four breaths to normalize the breathing pattern). The tests will be carried out once with the subjects seated comfortably and one other in supine position on a cot. In both positions, care will be taken to maintain the subjects comfortable with the neck in a neutral position, as it has been documented that the position of the head exerts an influence over upper airway collapsibility [40]. All maneuvers will be performed with the subjects awake and wearing a nose clip. The airflow and the mouth pressure signals will be low-pass filtered and sampled at 200 Hz. Both digital signals will be displayed in real time on the monitor and stored on the computer for subsequent analysis. Signal analysis and solenoid valve control will be performed using software written in Labview 8.2 (National Instruments) developed by the Italian National Research Council, Institute of Biomedicine and Molecular Immunology "A. Monroy".

NEP application during tidal expiration produces an immediate peak flow followed by a sudden drop of a variable degree. Upper airway collapsibility is evaluated by measuring flow limitation as flow drop (Δ), expressed as the percentage of peak flow immediately after NEP administration. To avoid reflex and voluntary reactions to the NEP stimulus, the minimal flow will be identified in the first 200 ms of NEP administration [41]. Upper airway collapsibility is also evaluated by measuring V0.2 immediately after NEP administration (Figure 3). These values are expressed as the percentage of mean inspiratory volume of the three breaths preceding NEP administration. Measured volumes are accepted only when differences between inspiration and expiration for each of the three previous breaths are less than 10%. Values of V0.2 and Δ (%) are calculated as the mean of four measurements.

Standard overnight polysomnography

Nocturnal polysomnography will be carried out using the Embla Somnologica Studio - EMBLA A10, version 3.1.2. (Flaga hf. Medical Devices, Iceland) sleep analysis system. The following signals will be recorded: electroencephalogram (F4-M1, C4-M1, O2-M1, and backup electrodes F3, C3, O1 and M2), electrooculograms (E1-M2, E2-M2), chin and tibials electromyography, electrocardiogram, oxygen saturation, pulse rate, oronasal airflow (nasal canula and thermistor), respiratory effort (thoracic and abdominal Xtrace model straps), snoring, and body position. The patients will be instructed to remain relaxed and sleep naturally as at home. Throughout the night, the subjects will be monitored by a technician experienced in polysomnography [42]. The reading will be performed by professionals who were blinded to the result of the NEP test, following the guidelines of the American Academy of Sleep Medicine [43] and criteria of the Brazilian Sleep Society.

Apneas are defined as lack of airflow or a reduction ≥90% in the airflow signal for at least 10 s. Hypopneas are defined as discernible drop in flow by ≥ 30% of baseline for a period lasting at least 10 s followed by a SaO2 fall ≥4%. AHI will be calculated as number of (apneas + hypopneas)/h of total sleep time. Subjects with AHI ≥5 will be classified as OSA [42,43].

Quality control

In order to ensure data quality, the physiotherapists and physicians in charge of data collection will receive specific training. Periodic external monitoring will be performed to verify adequate application of methodology in performing examinations and data collection.

Calculation of sample size and statistical analysis

The calculation of sample size was based on the correlation reported by Insalaco et al. [44] between Δ(%) and AHI in patients with OSA (r = 0.37). For a bidirectional alpha value of 0.05 and 90% power, a minimum number of 82 subjects will be necessary.

Kolmogorov-Smirnov normality test will first be performed in order to determine the presence or absence of a normal distribution sample. Descriptive analysis will be performed, with the data expressed as either mean and standard deviation or median values and 95% confidence intervals, when appropriate. One-way analysis of variance (ANOVA) will be used for comparisons between work shifts once the samples have a normal distribution. V0.2 and Δ(%) values will be linearly correlated with the AHI, for which either Pearson's or Spearman's correlation test will be used, depending on the sample distribution. Either the non-paired Student's t-test or Mann-Whitney test will be used for comparisons between individuals with and without OSA. Logistic regression for the analysis of continuous factors with categorical responses will be performed. Receiver operating characteristic (ROC) curves will be constructed to determine the sensitivity (true positive rate) versus 100-specificity (false positive rate) at various levels of the measured Δ (%) and V0.2 (%) to identify the cut-off value yielding the largest number of correctly classified patients. The statistical analysis will be performed by an experienced statistician using the JMP commercial program (version 8.0, SAS Institute Inc.) and SPSS program (version 16.0, Somers NY). A 5% level of significance and 95% confidence interval will be applied.

Ethical considerations

The present study is in accordance with the Helsinki Declaration and the Regulatory Guidelines and Norms for Research Involving Human Subjects of the National Health Board of the Brazilian Health Ministry issued in October 1996. This study received approval from the Human Research Ethics Committee of the Nove de Julho University (Brazil) under process number 329445/2010. Informed consent will be required to all subjects.

All procedures of the study will be confidential. The professional drivers diagnosed for OSA will be referred to the Sleep Medicine service and immediately forwarded to adequate treatment in order to treat the sleep respiratory disorder.


Discussion

Despite the abundance of scientific evidence, OSA is still underdiagnosed in the general population. This is probably due to multiple causes, such as deficiency of knowledge on the part of physicians and also the limited access of the patients to diagnosis and treatment of OSA [45]. In addition, diagnostic procedures are expensive, and predictive criteria are still unsatisfactory. Obesity parameters are important predictors, although not all OSA patients are obese and not all obese subjects have OSA. The identification of new markers of OSA would be useful.

The aim of the present protocol study is to determine whether the NEP test could be used as a screening tool for OSA and the prevalence of this condition among a population of professional interstate bus drivers. Because increased upper airway collapsibility is one of

the main determinants of OSA [21], the response to the application of NEP could be a predictor of this disorder.

With the enrollment of this study protocol, the expectation is to encounter predictive NEP values for different degrees of OSA. It's a daytime, low-cost screening method that could be included in a preventive strategy in order to contribute toward an early diagnosis of this condition and reduce its impact and complications among professional interstate bus drivers.


Competing interests

The authors declare that they have no competing interests.


Authors' contributions

LVFO, GI and RPH provided the idea for the study, established the hypothesis and wrote the original proposal. SR, GI and AS developed the NEP system and software used in this protocol. RPH, IRS, ICA, NSFJ, LCG, PNN and SRN took part in the data collection. ICA, NSFJ, CSO, PTC and IRS participated in the organization and reporting of the data. FSSLF, LMMS, SR, LCG and SRN worked on the data collection, statistical analysis, evaluation and presentation of the results. RPH, AB and LVFO significantly contributed to writing this protocol paper with the input of all co-authors, while GI, AS, FSSLF, GLF and LMMS were involved in critically revising the manuscript. All authors read and approved the final manuscript.


Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2466/11/57/prepub


Acknowledgements

The Sleep Laboratory receives funding from the Nove de Julho University (Brazil) and research projects approved by the Brazilian fostering agencies Fundaçao de Amparo a Pesquisa do Estado de Sao Paulo (local acronym FAPESP) (protocol number 2003/01810-4) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (local acronym CNPq) (Research Productivity modality - process number 307618/2010-2). GI, AS and SR are researchers from Italian National Research Council Institute of Biomedicine and Molecular Immunology "A. Monroy". The authors are grateful to the roadway transportation company that allowed the development of this protocol study.


References
Pandi-Perumal SR,Verster JC,Kayumov L,Lowe AD,Santana MG,Pires ML,Tufik S,Mello MT,Sleep disorders, sleepiness and traffic safety: a public health menaceBraz J Med Biol ResYear: 200639786387110.1590/S0100-879X200600070000316862276
Connor J,Norton R,Ameratunga S,Robinson E,Wigmore B,Jackson R,Prevalence of driver sleepiness in a random population-based sample of car drivingSleepYear: 200124668869411560182
Garbarino S,[Sleep disorders and road accidents in truck drivers]G Ital Med Lav ErgonYear: 200830329129619069233
Instituto de Pesquisa Econômica Aplicada IImpactos sociais e econômicos dos acidentes de trânsito nas aglomerações urbanasYear: 200121Brasilia
Punjabi NM,The epidemiology of adult obstructive sleep apneaProc Am Thorac SocYear: 20085213614310.1513/pats.200709-155MG18250205
Tufik S,Santos-Silva R,Taddei JA,Bittencourt LR,Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep StudySleep MedYear: 201011544144610.1016/j.sleep.2009.10.00520362502
Sassani A,Findley LJ,Kryger M,Goldlust E,George C,Davidson TM,Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndromeSleepYear: 200427345345815164898
Pack AI,Dinges D,Maislin G,A study of prevalence of sleep apnea among commercial truck driversFederal Motor Carrier Safety Administration Publication, Washington, DCYear: 2002 DOT-RT-02-030.
Aguiar M,Valenca J,Felizardo M,Caeiro F,Moreira S,Staats R,Bugalho de Almeida AA,Obstructive sleep apnoea syndrome as a cause of road traffic accidentsRev Port PneumolYear: 200915341943119401792
Sallinen M,Harma M,Mutanen P,Ranta R,Virkkala J,Muller K,Sleepiness in various shift combinations of irregular shift systemsInd HealthYear: 200543111412210.2486/indhealth.43.11415732313
Nieto FJ,Young TB,Lind BK,Shahar E,Samet JM,Redline S,D'Agostino RB,Newman AB,Lebowitz MD,Pickering TG,Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health StudyJAMAYear: 2000283141829183610.1001/jama.283.14.182910770144
Peker Y,Hedner J,Kraiczi H,Loth S,Respiratory disturbance index: an independent predictor of mortality in coronary artery diseaseAm J Respir Crit Care MedYear: 20001621818610903224
Drager LF,Bortolotto LA,Lorenzi MC,Figueiredo AC,Krieger EM,Lorenzi-Filho G,Early signs of atherosclerosis in obstructive sleep apneaAm J Respir Crit Care MedYear: 2005172561361810.1164/rccm.200503-340OC15901608
Kim HC,Young T,Matthews CG,Weber SM,Woodward AR,Palta M,Sleep-disordered breathing and neuropsychological deficits. A population-based studyAm J Respir Crit Care MedYear: 19971566181318199412560
Sharma H,Sharma SK,Kadhiravan T,Mehta M,Sreenivas V,Gulati V,Sinha S,Pattern & correlates of neurocognitive dysfunction in Asian Indian adults with severe obstructive sleep apnoeaIndian J Med ResYear: 201013240941420966519
Flemons WW,Tsai W,Quality of life consequences of sleep-disordered breathingJ Allergy Clin ImmunolYear: 1997992S75075610.1016/S0091-6749(97)70123-49042067
Baldwin CM,Ervin AM,Mays MZ,Robbins J,Shafazand S,Walsleben J,Weaver T,Sleep disturbances, quality of life, and ethnicity: the Sleep Heart Health StudyJ Clin Sleep MedYear: 20106217618320411696
Smith R,Ronald J,Delaive K,Walld R,Manfreda J,Kryger MH,What are obstructive sleep apnea patients being treated for prior to this diagnosis?ChestYear: 2002121116417210.1378/chest.121.1.16411796446
Otake K,Delaive K,Walld R,Manfreda J,Kryger MH,Cardiovascular medication use in patients with undiagnosed obstructive sleep apnoeaThoraxYear: 200257541742210.1136/thorax.57.5.41711978918
Gold AR,Schwartz AR,The pharyngeal critical pressure. The whys and hows of using nasal continuous positive airway pressure diagnosticallyChestYear: 199611041077108810.1378/chest.110.4.10778874271
Fogel RB,Malhotra A,White DP,Sleep. 2: pathophysiology of obstructive sleep apnoea/hypopnoea syndromeThoraxYear: 200459215916310.1136/thorax.2003.01585914760159
Bradley TD,Brown IG,Grossman RF,Zamel N,Martinez D,Phillipson EA,Hoffstein V,Pharyngeal size in snorers, nonsnorers, and patients with obstructive sleep apneaN Engl J MedYear: 1986315211327133110.1056/NEJM1986112031521053773955
Schwab RJ,Gefter WB,Hoffman EA,Gupta KB,Pack AI,Dynamic upper airway imaging during awake respiration in normal subjects and patients with sleep disordered breathingAm Rev Respir DisYear: 19931485138514008239180
Schellenberg JB,Maislin G,Schwab RJ,Physical findings and the risk for obstructive sleep apnea. The importance of oropharyngeal structuresAm J Respir Crit Care MedYear: 20001622 Pt 174074810934114
Anch AM,Remmers JE,Sauerland EK,Degroot WJ,Oropharyngeal patency during walking and sleep in the Pickwickian syndrome: electromyographic activity of the tensor veli palatiniElectromyogr Clin NeurophysiolYear: 1981212-33173307262011
Fogel RB,Malhotra A,Pillar G,Edwards JK,Beauregard J,Shea SA,White DP,Genioglossal activation in patients with obstructive sleep apnea versus control subjects. Mechanisms of muscle controlAm J Respir Crit Care MedYear: 2001164112025203011739130
Brennick MJ,Pack AI,Ko K,Kim E,Pickup S,Maislin G,Schwab RJ,Altered upper airway and soft tissue structures in the New Zealand Obese mouseAm J Respir Crit Care MedYear: 2009179215816918996996
Koulouris NG,Valta P,Lavoie A,Corbeil C,Chasse M,Braidy J,Milic-Emili J,A simple method to detect expiratory flow limitation during spontaneous breathingEur Respir JYear: 19958230631310.1183/09031936.95.080203067758567
Baydur A,Wilkinson L,Mehdian R,Bains B,Milic-Emili J,Extrathoracic expiratory flow limitation in obesity and obstructive and restrictive disorders: effects of increasing negative expiratory pressureChestYear: 200412519810510.1378/chest.125.1.9814718427
Van Meerhaeghe A,Delpire P,Stenuit P,Kerkhofs M,Operating characteristics of the negative expiratory pressure technique in predicting obstructive sleep apnoea syndrome in snoring patientsThoraxYear: 2004591088388810.1136/thx.2003.01527115454655
Liistro G,Veriter C,Dury M,Aubert G,Stanescu D,Expiratory flow limitation in awake sleep-disordered breathing subjectsEur Respir JYear: 199914118519010.1034/j.1399-3003.1999.14a31.x10489849
Verin E,Tardif C,Portier F,Similowski T,Pasquis P,Muir JF,Evidence for expiratory flow limitation of extrathoracic origin in patients with obstructive sleep apnoeaThoraxYear: 200257542342810.1136/thorax.57.5.42311978919
WHOObesity: preventing and managing the global epidemic. Report of a WHO ConsultationWHO Technical Report Series 894Year: 2000Geneva World Health Organization
Brodsky L,Modern assessment of tonsils and adenoidsPediatr Clin North AmYear: 1989366155115692685730
Mallampati SR,Gatt SP,Gugino LD,Desai SP,Waraksa B,Freiberger D,Liu PL,A clinical sign to predict difficult tracheal intubation: a prospective studyCan Anaesth Soc JYear: 198532442943410.1007/BF030113574027773
Netzer NC,Stoohs RA,Netzer CM,Clark K,Strohl KP,Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndromeAnn Intern MedYear: 1999131748549110507956
Johns MW,A new method for measuring daytime sleepiness: the Epworth sleepiness scaleSleepYear: 19911465405451798888
Pereira CAC,II Consenso Brasileiro de EspirometriaJ PneumolYear: 200228supl3S1S82
Quanjer PH,Tammeling GJ,Cotes JE,Pedersen OF,Peslin R,Yernault JC,Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory SocietyEur Respir J SupplYear: 1993165408499054
Isono S,Tanaka A,Tagaito Y,Ishikawa T,Nishino T,Influences of head positions and bite opening on collapsibility of the passive pharynxJ Appl PhysiolYear: 200497133934610.1152/japplphysiol.00907.200315020573
Romano S,Salvaggio A,Hirata RP,Lo Bue A,Picciolo S,Oliveira LVF,Insalaco G,Upper airway collapsibility evaluated by negative expiratory pressure test in severe obstructive sleep apneaClinicsYear: 20116656
Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task ForceSleepYear: 199922566768910450601
American Academy of Sleep MedicineThe AASM Manual for the scoring of sleep and associated eventsRules, terminology and technical especificationsYear: 2007
Insalaco G,Romano S,Marrone O,Salvaggio A,Bonsignore G,A new method of negative expiratory pressure test analysis detecting upper airway flow limitation to reveal obstructive sleep apneaChestYear: 200512842159216510.1378/chest.128.4.215916236869
Logan AG,Perlikowski SM,Mente A,Tisler A,Tkacova R,Niroumand M,Leung RS,Bradley TD,High prevalence of unrecognized sleep apnoea in drug-resistant hypertensionJ HypertensYear: 200119122271227710.1097/00004872-200112000-0002211725173

Figures

[Figure ID: F1]
Figure 1 

Design of the study. Abbreviations: ESS - Epworth Sleepiness Scale; CNR - Consiglio Nazionale delle Ricerche; NEP - negative expiratory pressure.



[Figure ID: F2]
Figure 2 

Schematic representation of the negative expiratory pressure apparatus.



[Figure ID: F3]
Figure 3 

Measurements techniques for upper airway collapsibility evaluated as expiratory volume in 0.2s (V0.2 - percent of the mean inspiratory volume of the three breaths preceding NEP application) and as the flow drop (Δ- expressed as the percent of the peak flow).



Article Categories:
  • Study Protocol


Previous Document:  High resolution profiling of human exon methylation by liquid hybridization capture-based bisulfite ...
Next Document:  The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme gene and cancer risk:...